D&O Initial Disclosure Notice

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and ASX
Name of listed issuer: Oceania Healthcare Limited
Date this disclosure made: 20 September 2021
Date on which issuer listed or appointment made: 17 September 2021

Director or senior manager giving disclosure
Full name(s): Robert Hamilton
Name of listed issuer: Oceania Healthcare Limited
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Director

Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares
Number held in class: 40,500
Nature of relevant interest:
Registered and beneficial owner
of shares
Current registered holder: Robert Hamilton

Summary of specified derivatives relevant interest (if applicable)
Type of derivative: N/A
Class of underlying financial products: N/A

Details of derivative
The notional value of the derivative (if any) or the notional
amount of underlying products (if any):
N/A
A statement as to whether the derivative is cash settled or
physically settled:
N/A
Maturity date of the derivative (if any): N/A
Expiry date of the derivative (if any): N/A
The price specified in the terms of the derivative (if any): N/A
Any other details needed to understand how the amount of
the consideration payable under the derivative or the value
of the derivative is affected by the value of the underlying
financial products:
N/A

For that derivative: -
Parties to the derivative: N/A
If the director or senior manager is not a party to the
derivative, the nature of the relevant interest in the
derivative:
N/A

Certification
I certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I
am duly authorised to make this disclosure by all persons
for whom it is made.

Signature of director or officer:

Date of signature:
or
Signature of person authorised to sign on behalf of director
or officer:


Date of signature: 20 September 2021
Name and title of authorised person: Anna Thorburn
Group General Counsel